Clinico-demographic profile of deceased patients with coronavirus disease in a tertiary care centre of central India

Rupali A. Patle, Ashok R. Jadhao, Priya B. Dhengre, Manjusha A. Dhoble


Background: The covid pandemic started from Hubei, Wuhan in December 2020 then covered many other countries including India. Understanding the demographic and clinical characteristics of deceased COVID-19 patients could inform public health interventions focusing on preventing mortality due to COVID-19. The present study was done with the objective of studying the socio-demographic and clinical profile of deceased patients with coronavirus disease.

Methods: This is a hospital based cross-sectional study on 1190 deceased patients of coronavirus disease in a tertiary care hospital of central India which is a dedicated covid hospital from 11 March 2020 to 28 February 2021. Socio-demographic and clinical characteristics of deceased patients were recorded.

Results: Overall case fatality rate was 13.24%. Maximum number of deaths occurred in the month of August 2020 and September 2020 were 372 (31.26%) and 477 (40.08%). It was higher in the males 791 (66.47%) as compared to females 399 (33.53%), but the difference was not significant. The most common symptom was fever on hospitalization 924 (77.65%), followed by generalized weakness 771 (64.79%). 352 (29.58%) patients died within 24 hours of the admission to hospital. Hypertension and type 2 diabetes mellitus were the most prevalent morbidity in 557 (46.80%) and 357 (30.00%). It was found that 232 (19.50%) deceased patients had oxygen saturation less than 50% on admission.

Conclusions: Higher age and presence of co-morbidities at the time of admission were significantly associated with mortality.


COVID-19, Deaths, Coronavirus, Comorbidities, Symptoms, Duration of stay

Full Text:



Purcell LN, Charles AG. An invited commentary on World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID- 19)": emergency or new reality? Int J Surg. 2020;76:111.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.

Tambe MP, Parande MA, Tapare VS, Borle PS, Lakde RN, Shelke SC. An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra. Ind J Pub Heal. 2020;64(6):183-6.

GOM. DMER, MEDD. Report of Covid 19 cases. Analytics: Medical Education and Drugs Department. Data: Public Health Department. 2021. Last accessed on 9th March, 2021.

The Hindu. Fact sheet: Imperatives after India’s September virus peak, 2020. Available at: Accessed on 3 March 2021.

One of the highest globally, India’s Recovery Rate now nearly 97%, Press Information Bureau. 2021 Last accessed on 2 February, 2021.

Ghosh AA, Nundy SB, Mallick TK. How India is dealing with COVID-19 pandemic. Sensors International. 2020;1:100021.

Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol. 2020;45(8):100618.

Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage: a review. Life Sci. 2020;255:117839.

Soni SL, Kajal K, Yaddanapudi LN, Malhotra P, Puri GD, Bhalla A, et al. Demographic and clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J Med Res. 2020.

Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J. Pediatr. 2020;87(4):281-6.

Ministry of Health and Family Welfare. Adequate health infrastructure and health facilities set up for COVID-19management. PIB Delhi. 2020. Last accessed on 23 February, 2021.

Asirvatham ES, Sarman CJ, Saravanamurthy SP, Mahalingam P, Maduraipandian SE, Lakshmanan J. Who is dying from COVID-19 and when? An Analysis of fatalities in Tamil Nadu, India. Clinic Epidemiol Glob Heal. 2021;9:275-9.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:1091.

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;12(10):9959-81.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77.

Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Care. 2020;24(1):405.

National IIPS. Family Health Survey-2017 (NFHS-4). New Delhi: Ministry of Heallth and Family Welfare, Government of India. 2017. Last accessed 25 February, 2021

Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.

Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):1-6.

Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res. 2020;158:104931.

CDC. Severe Outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12-March 16, 2020. Morb Mortal Wkly Rep. 2020;69(12):343-6.

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959-81.

Liu H, Chen S, Liu M, Nie N Lu H. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis. 2020;11(3):668-78.

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020:1-8.

Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PloS One. 2020;15(6):0234765.

Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020;95:1138-47.

Mejıa F, Medina C, Cornejo E, Morello E, Vasquez S, Alave J, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020;15(12).

Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020;32(9):1869-78.